Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Memorial Sloan Kettering Cancer Center
Sponsor:
Collaborators:
Array BioPharma
University of Pittsburgh
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01991379
First received: November 18, 2013
Last updated: August 31, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: November 2018 (Final data collection date for primary outcome measure)